WESTON, Fla.--(BUSINESS WIRE)--Dec. 23, 2005--Apotex Corp. today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for zonisamide capsules in 25 mg, 50 mg and 100 mg strengths. Shipments of the product will commence immediately.
